Featured Research

from universities, journals, and other organizations

HIV Patients Have No Progression Of HIV After Liver Transplants, Pitt Study Reports

Date:
May 7, 2002
Source:
University Of Pittsburgh Medical Center
Summary:
Patients with the human immunodeficiency virus (HIV) who underwent liver transplantation for hepatitis C virus (HCV) did not have further progression of their HIV after transplantation despite their taking immune-suppressing anti-rejection drugs, according to a University of Pittsburgh study presented today at the American Transplant Congress at the Marriott Wardman Park Hotel in Washington, D.C. However, as with many hepatitis C patients receiving liver transplants, HCV recurred in three of the six HIV patients who survived their transplants.

WASHINGTON, D.C., April 28 – Patients with the human immunodeficiency virus (HIV) who underwent liver transplantation for hepatitis C virus (HCV) did not have further progression of their HIV after transplantation despite their taking immune-suppressing anti-rejection drugs, according to a University of Pittsburgh study presented today at the American Transplant Congress at the Marriott Wardman Park Hotel in Washington, D.C. However, as with many hepatitis C patients receiving liver transplants, HCV recurred in three of the six HIV patients who survived their transplants.

Michael E. de Vera, M.D., a clinical transplant fellow at the University of Pittsburgh’s Thomas E. Starzl Transplantation Institute, reported that in the six surviving patients, all of whom have continued highly active anti-retroviral therapy (HAART) along with immunosuppression regimens, HIV viral loads have remained undetectable since their transplants, one for more than four years. Of the three who developed HCV recurrence, one patient has not required treatment, one has responded well to treatment consisting of interferon and ribavirin; the third patient has developed cirrhosis of the liver but has normal bilirubin and a functioning graft.

“HIV progression can be controlled after transplantation with HAART, and HCV recurrence appears to follow a similar course as seen in patients without HIV co-infection, with similar responses to antiviral therapy,” Dr. de Vera stated.

Eight patients with HIV and HCV co-infection have been transplanted at the University of Pittsburgh since 1997. Two died for reasons unrelated to complications of either their HIV or HCV.


Story Source:

The above story is based on materials provided by University Of Pittsburgh Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pittsburgh Medical Center. "HIV Patients Have No Progression Of HIV After Liver Transplants, Pitt Study Reports." ScienceDaily. ScienceDaily, 7 May 2002. <www.sciencedaily.com/releases/2002/04/020429072032.htm>.
University Of Pittsburgh Medical Center. (2002, May 7). HIV Patients Have No Progression Of HIV After Liver Transplants, Pitt Study Reports. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2002/04/020429072032.htm
University Of Pittsburgh Medical Center. "HIV Patients Have No Progression Of HIV After Liver Transplants, Pitt Study Reports." ScienceDaily. www.sciencedaily.com/releases/2002/04/020429072032.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
CDC Calls for New Ebola Safety Guidelines

CDC Calls for New Ebola Safety Guidelines

AP (Oct. 20, 2014) Centers for Disease Control and Prevention Director Dr. Tom Frieden laid out new guidelines for health care workers when dealing with the deadly Ebola virus including new precautions when taking off personal protective equipment. (Oct. 20) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins